LONCASTUXIMAB TESIRINE

LONCASTUXIMAB TESIRINE was reported 410 times

LONCASTUXIMAB TESIRINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CUTANEOUS COLLAGENOUS VASCULOPATHY 2 0.2000
1 TRANSIENT HEPATIC ATTENUATION DIFFERENCES 1 0.1667
2 SLIPPING RIB SYNDROME 2 0.0556
3 CELL MARKER DECREASED 1 0.0370
4 CSF LYMPHOCYTE COUNT ABNORMAL 1 0.0278
5 CARDIAC FAILURE HIGH OUTPUT 4 0.0166
6 COLLAGEN-VASCULAR DISEASE 1 0.0143
7 RETICULOCYTOPENIA 1 0.0068
8 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 6 0.0063
9 CNS VENTRICULITIS 2 0.0061
10 FUSARIUM INFECTION 4 0.0057
11 MENINGITIS PNEUMOCOCCAL 2 0.0055
12 GLOMERULONEPHRITIS CHRONIC 1 0.0053
13 NEPHRITIC SYNDROME 1 0.0032
14 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 6 0.0027
15 BONE MARROW INFILTRATION 1 0.0026
16 GASTRIC FISTULA 1 0.0022
17 MINIMAL RESIDUAL DISEASE 1 0.0021
18 RENAL HAEMATOMA 1 0.0019
19 FOCAL NODULAR HYPERPLASIA 1 0.0019
20 TRANSAMINASES ABNORMAL 1 0.0017
21 DIFFUSE LARGE B-CELL LYMPHOMA 13 0.0017
22 NEUROPSYCHOLOGICAL SYMPTOMS 1 0.0017
23 BILIARY OBSTRUCTION 2 0.0015
24 CAPILLARY LEAK SYNDROME 3 0.0014
25 PHOTOSENSITIVITY REACTION 21 0.0013
26 CAMPYLOBACTER INFECTION 1 0.0012
27 SCROTAL SWELLING 1 0.0011
28 SKIN TOXICITY 6 0.0011
29 NEUTROPENIC INFECTION 1 0.0010
30 TELANGIECTASIA 1 0.0010
31 ASTERIXIS 1 0.0009
32 CHRONIC RESPIRATORY FAILURE 1 0.0008
33 B-LYMPHOCYTE COUNT DECREASED 1 0.0007
34 EFFUSION 1 0.0007
35 IMMUNOGLOBULINS DECREASED 1 0.0007
36 SKIN HYPERTROPHY 2 0.0007
37 NOROVIRUS INFECTION 1 0.0007
38 PARAINFLUENZAE VIRUS INFECTION 1 0.0007
39 CYTOPENIA 8 0.0007
40 INTERCEPTED MEDICATION ERROR 3 0.0006
41 FUNGAEMIA 1 0.0006
42 RASH VESICULAR 3 0.0006
43 HYPERVOLAEMIA 3 0.0006
44 PRODUCT TEMPERATURE EXCURSION ISSUE 3 0.0006
45 ACUTE SINUSITIS 1 0.0006
46 GASTROINTESTINAL OEDEMA 1 0.0006
47 PNEUMOMEDIASTINUM 1 0.0006
48 EARLY SATIETY 1 0.0005
49 NAIL DISCOLOURATION 2 0.0005
50 HYPOGAMMAGLOBULINAEMIA 3 0.0005
51 CARDIOTOXICITY 4 0.0004
52 EOSINOPHIL COUNT DECREASED 1 0.0004
53 ENTEROCOCCAL INFECTION 2 0.0004
54 EYE OEDEMA 1 0.0004
55 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9 0.0004
56 SUNBURN 3 0.0004
57 HYPERPARATHYROIDISM SECONDARY 1 0.0004
58 PLEURAL EFFUSION 24 0.0004
59 HEPATOSPLENOMEGALY 1 0.0004
60 PERICARDIAL EFFUSION 9 0.0004
61 FAILURE TO THRIVE 2 0.0004
62 RADICULOPATHY 1 0.0004
63 GASTRIC PERFORATION 1 0.0004
64 HYDROCEPHALUS 2 0.0004
65 PERIORBITAL SWELLING 2 0.0004
66 HAEMOTHORAX 1 0.0003
67 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 2 0.0003
68 CREPITATIONS 1 0.0003
69 BLOOD CULTURE POSITIVE 1 0.0003
70 PNEUMONIA BACTERIAL 3 0.0003
71 UROSEPSIS 3 0.0003
72 POLYMYALGIA RHEUMATICA 1 0.0003
73 PNEUMONIA VIRAL 1 0.0003
74 PRODUCT PREPARATION ISSUE 2 0.0003
75 BONE MARROW FAILURE 6 0.0003
76 HEPATIC CYST 1 0.0003
77 B-CELL LYMPHOMA 1 0.0003
78 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
79 GLOSSITIS 1 0.0003
80 DISEASE PROGRESSION 33 0.0003
81 GRAFT VERSUS HOST DISEASE 2 0.0003
82 ARTHROPOD BITE 2 0.0003
83 HEPATOTOXICITY 6 0.0003
84 HEPATIC NECROSIS 1 0.0003
85 GASTRIC INFECTION 1 0.0003
86 OEDEMA 14 0.0003
87 VENOUS THROMBOSIS 1 0.0003
88 GENERALISED OEDEMA 3 0.0002
89 HEPATIC LESION 1 0.0002
90 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
91 DIVERTICULUM INTESTINAL 1 0.0002
92 TUMOUR LYSIS SYNDROME 2 0.0002
93 CYTOMEGALOVIRUS INFECTION REACTIVATION 1 0.0002
94 ILEUS PARALYTIC 1 0.0002
95 NEPHROGENIC ANAEMIA 1 0.0002
96 PRODUCT DISTRIBUTION ISSUE 2 0.0002
97 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
98 CARDIAC TAMPONADE 1 0.0002
99 AUTOIMMUNE DISORDER 2 0.0002
100 CYTOKINE RELEASE SYNDROME 4 0.0002
101 KLEBSIELLA INFECTION 1 0.0002
102 PRODUCT PREPARATION ERROR 4 0.0002
103 LYMPHOMA 3 0.0002
104 BLOOD LACTIC ACID INCREASED 1 0.0002
105 RASH MACULO-PAPULAR 4 0.0002
106 PANCYTOPENIA 10 0.0002
107 ANGIOPATHY 1 0.0002
108 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
109 PLEURISY 1 0.0002
110 DERMATITIS ACNEIFORM 1 0.0002
111 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
112 INFUSION SITE EXTRAVASATION 1 0.0002
113 CORONAVIRUS INFECTION 1 0.0002
114 SKIN MASS 1 0.0001
115 MENINGITIS 1 0.0001
116 AUTOIMMUNE HEPATITIS 1 0.0001
117 HYPERTRANSAMINASAEMIA 1 0.0001
118 LYMPHOPENIA 2 0.0001
119 THERMAL BURN 1 0.0001
120 NEUTROPENIC SEPSIS 1 0.0001
121 LIVER FUNCTION TEST INCREASED 3 0.0001
122 DERMATITIS BULLOUS 1 0.0001
123 ASCITES 4 0.0001
124 FEBRILE NEUTROPENIA 9 0.0001
125 THROMBOCYTOPENIA 15 0.0001
126 NEUTROPENIA 18 0.0001
127 INTERCEPTED PRODUCT ADMINISTRATION ERROR 1 0.0001
128 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
129 NEUTROPHIL COUNT DECREASED 5 0.0001
130 SECOND PRIMARY MALIGNANCY 1 0.0001
131 PSEUDOMONAS INFECTION 1 0.0001
132 NEOPLASM PROGRESSION 4 0.0001
133 SEPTIC SHOCK 5 0.0001
134 PRODUCT COMMUNICATION ISSUE 1 0.0001
135 LUNG INFILTRATION 1 0.0001
136 PURPURA 1 0.0001
137 PNEUMONITIS 3 0.0001
138 LIP DRY 1 0.0001
139 END STAGE RENAL DISEASE 2 0.0001
140 HEPATIC ENCEPHALOPATHY 1 0.0001
141 BLISTER 6 0.0001
142 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
143 SQUAMOUS CELL CARCINOMA 1 0.0001
144 HAEMATOTOXICITY 1 0.0001
145 ACUTE RESPIRATORY FAILURE 2 0.0001
146 RENAL TUBULAR NECROSIS 1 0.0001
147 HEPATOMEGALY 1 0.0001
148 LEUKOPENIA 5 0.0001
149 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
150 OEDEMA PERIPHERAL 12 0.0001
151 TEMPERATURE INTOLERANCE 1 0.0001
152 FULL BLOOD COUNT ABNORMAL 1 0.0001
153 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
154 SKIN INFECTION 1 0.0001
155 NEPHROPATHY TOXIC 1 0.0001
156 HEPATIC ENZYME INCREASED 6 0.0001
157 EYELID OEDEMA 1 0.0001
158 HYPOXIA 3 0.0001
159 COVID-19 PNEUMONIA 1 0.0001
160 PLATELET COUNT DECREASED 9 0.0001
161 ANAEMIA 16 0.0001
162 INTERSTITIAL LUNG DISEASE 4 0.0001
163 SMALL INTESTINAL OBSTRUCTION 1 0.0001
164 HYPERCALCAEMIA 1 0.0001
165 ABNORMAL WEIGHT GAIN 1 0.0001
166 ILEUS 1 0.0001
167 HEPATIC FUNCTION ABNORMAL 3 0.0001
168 DEATH 69 0.0001
169 SECRETION DISCHARGE 1 0.0001
170 COVID-19 14 0.0001
171 SKIN ULCER 2 0.0001
172 NODULE 1 0.0001
173 TOOTH INFECTION 1 0.0001
174 MALIGNANT MELANOMA 1 0.0001
175 RASH 32 0.0001
176 SEPSIS 8 0.0001
177 SKIN REACTION 1 0.0001
178 BLINDNESS UNILATERAL 1 0.0001
179 IMPAIRED QUALITY OF LIFE 1 0.0001
180 MYELODYSPLASTIC SYNDROME 1 0.0001
181 INFECTION 10 0.0001
182 HYPERTHYROIDISM 1 0.0001
183 LABORATORY TEST ABNORMAL 2 0.0001
184 PULMONARY MASS 1 0.0001
185 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
186 THERAPY PARTIAL RESPONDER 1 0.0001
187 METABOLIC ACIDOSIS 2 0.0001
188 MUSCLE TIGHTNESS 1 0.0001
189 CYTOMEGALOVIRUS INFECTION 1 0.0001
190 CELLULITIS 3 0.0001
191 PERICARDITIS 1 0.0001
192 FACE OEDEMA 1 0.0001
193 CANDIDA INFECTION 1 0.0001
194 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
195 HAEMATURIA 2 0.0001
196 HYPERKALAEMIA 2 0.0001
197 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
198 GOUT 1 0.0001
199 HYPERGLYCAEMIA 2 0.0001
200 HEPATIC STEATOSIS 1 0.0001
201 THINKING ABNORMAL 1 0.0001
202 PROTEINURIA 1 0.0001
203 CHOLESTASIS 1 0.0001
204 DRUG INTOLERANCE 5 0.0001
205 DERMATITIS 1 0.0000
206 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
207 SWELLING FACE 3 0.0000
208 MENTAL DISORDER 2 0.0000
209 PRODUCT PRESCRIBING ISSUE 1 0.0000
210 TRANSAMINASES INCREASED 1 0.0000
211 ORAL PAIN 1 0.0000
212 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
213 PNEUMONIA 14 0.0000
214 BLOOD GLUCOSE DECREASED 2 0.0000
215 RESPIRATORY FAILURE 3 0.0000
216 ATRIAL FIBRILLATION 4 0.0000
217 AGEUSIA 1 0.0000
218 PNEUMONIA ASPIRATION 1 0.0000
219 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
220 RENAL FAILURE 5 0.0000
221 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
222 BLOOD BILIRUBIN INCREASED 1 0.0000
223 RASH PRURITIC 2 0.0000
224 RESPIRATORY DISTRESS 1 0.0000
225 MENTAL STATUS CHANGES 1 0.0000
226 MEDICATION ERROR 2 0.0000
227 RED BLOOD CELL COUNT DECREASED 1 0.0000
228 HYPERSOMNIA 1 0.0000
229 LIVER FUNCTION TEST ABNORMAL 1 0.0000
230 PRODUCT STORAGE ERROR 3 0.0000
231 RESPIRATORY DISORDER 1 0.0000
232 ILL-DEFINED DISORDER 2 0.0000
233 NERVOUS SYSTEM DISORDER 1 0.0000
234 DRUG-INDUCED LIVER INJURY 1 0.0000
235 NEUROPATHY PERIPHERAL 3 0.0000
236 NIGHT SWEATS 1 0.0000
237 BLOOD CREATININE INCREASED 2 0.0000
238 EYE DISORDER 1 0.0000
239 SKIN DISORDER 1 0.0000
240 HAEMOGLOBIN DECREASED 3 0.0000
241 DELIRIUM 1 0.0000
242 FATIGUE 22 0.0000
243 LYMPHADENOPATHY 1 0.0000
244 MYELOSUPPRESSION 1 0.0000
245 PANIC ATTACK 1 0.0000
246 ACCIDENTAL OVERDOSE 1 0.0000
247 INTESTINAL OBSTRUCTION 1 0.0000
248 CHRONIC KIDNEY DISEASE 2 0.0000
249 ACUTE KIDNEY INJURY 4 0.0000
250 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
251 ROAD TRAFFIC ACCIDENT 1 0.0000
252 RENAL IMPAIRMENT 2 0.0000
253 SKIN EXFOLIATION 2 0.0000
254 URINARY TRACT INFECTION 4 0.0000
255 DEVICE LEAKAGE 1 0.0000
256 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
257 THERAPY NON-RESPONDER 1 0.0000
258 SKIN DISCOLOURATION 1 0.0000
259 HYPOKALAEMIA 1 0.0000
260 COGNITIVE DISORDER 1 0.0000
261 SWELLING 2 0.0000
262 OCULAR HYPERAEMIA 1 0.0000
263 DYSPHAGIA 2 0.0000
264 DISEASE RECURRENCE 1 0.0000
265 PRODUCTIVE COUGH 1 0.0000
266 RASH ERYTHEMATOUS 1 0.0000
267 CONDITION AGGRAVATED 6 0.0000
268 FLUID RETENTION 1 0.0000
269 ILLNESS 2 0.0000
270 ABDOMINAL DISTENSION 2 0.0000
271 ECZEMA 1 0.0000
272 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
273 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
274 HYPONATRAEMIA 1 0.0000
275 FLATULENCE 1 0.0000
276 EYE IRRITATION 1 0.0000
277 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
278 THERAPEUTIC RESPONSE DECREASED 1 0.0000
279 OFF LABEL USE 14 0.0000
280 ERYTHEMA 3 0.0000
281 VISION BLURRED 2 0.0000
282 PYREXIA 5 0.0000
283 COUGH 4 0.0000
284 DYSPNOEA 8 0.0000
285 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
286 THERAPY INTERRUPTED 1 0.0000
287 DYSGEUSIA 1 0.0000
288 PERIPHERAL SWELLING 2 0.0000
289 DECREASED APPETITE 3 0.0000
290 CARDIAC FAILURE CONGESTIVE 1 0.0000
291 PROSTATE CANCER 1 0.0000
292 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
293 DIARRHOEA 8 0.0000
294 ABDOMINAL DISCOMFORT 2 0.0000
295 NO ADVERSE EVENT 2 0.0000
296 ADVERSE EVENT 1 0.0000
297 HYPERSENSITIVITY 2 0.0000
298 WEIGHT DECREASED 3 0.0000
299 PRODUCT USE ISSUE 2 0.0000
300 ASTHENIA 4 0.0000
301 BLOOD GLUCOSE INCREASED 2 0.0000
302 PRURITUS 4 0.0000
303 HYPOTENSION 2 0.0000
304 SINUSITIS 1 0.0000
305 CONSTIPATION 2 0.0000
306 INFLUENZA 1 0.0000
307 WEIGHT INCREASED 2 0.0000
308 MUSCULAR WEAKNESS 1 0.0000
309 DEPRESSION 2 0.0000
310 ABDOMINAL PAIN 2 0.0000
311 PALPITATIONS 1 0.0000
312 DRUG INEFFECTIVE 10 0.0000
313 NAUSEA 6 0.0000
314 DEHYDRATION 1 0.0000
315 DRY SKIN 1 0.0000
316 ANXIETY 2 0.0000
317 PAIN IN EXTREMITY 2 0.0000
318 HYPOAESTHESIA 1 0.0000
319 HEADACHE 4 0.0000
320 DRUG INTERACTION 1 0.0000
321 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
322 NASOPHARYNGITIS 1 0.0000
323 CHEST PAIN 1 0.0000
324 ABDOMINAL PAIN UPPER 1 0.0000
325 INCORRECT DOSE ADMINISTERED 1 0.0000
326 BACK PAIN 1 0.0000
327 FEELING ABNORMAL 1 0.0000
328 PRODUCT DOSE OMISSION ISSUE 1 0.0000
329 PAIN 2 0.0000
330 MALAISE 1 0.0000
331 DIZZINESS 1 0.0000